Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

145.89
Delayed Data
As of 4:15pm ET
 -0.07 / -0.05%
Today’s Change
137.17
Today|||52-Week Range
192.15
-5.95%
Year-to-Date
Kyle Bass: Troubling Times for His Strategy
4:47pm / GuruFocus News - Paid Partner Content
Allergan's (AGN) Sales Guidance for 2018 Lower Than Expected
Jan 09 / Zacks.com - Paid Partner Content
Nektar Boasts Strong Pipeline, Competition Remains a Woe
10:20am / Zacks.com - Paid Partner Content
Allergan to Cut Jobs Amid Loss of Exclusivity for Key Drugs
Jan 04 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close145.96
Today’s open145.73
Day’s range144.30 - 147.24
Volume2,347,320
Average volume (3 months)1,116,920
Market cap$44.3B
Data as of 4:15pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)-80.61%
Earnings growth (this year)+14.80%
Earnings growth (next 5 years)+8.10%
Revenue growth (last year)+76.71%
P/E ratio26.3
Price/Sales3.89
Price/Book1.50

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+1.25+0.80%
REGNRegeneron Pharmaceut...+3.86+1.04%
BAXBaxter International...+0.53+0.78%
ALXNAlexion Pharmaceutic...-2.36-1.90%
Data as of 4:00pm ET, 01/17/2018

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)$3.89
Annual revenue (last year)$11.3B
Annual profit (last year)$325.1M
Net profit margin5.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO &
Independent Non-Executive Director
Dominic Blakemore
Chief Financial Officer
John Miller
Corporate headquarters
Dublin, Dublin

Forecasts